iCRT-14

CAS : 677331-12-3

Ref. 3D-FI24534

Informations sur le produit

• Nom: iCRT-14
• Synonymes: 5-[[2,5-Dimethyl-1-(3-pyridinyl)-1H-pyrrol-3-yl]methylene]-3-phenyl-2,4-thiazolidinedioneiCRT 14iCRT14

Description

iCRT-14 is a drug that has been shown to be effective in the treatment of a number of different diseases. It is a pluripotent cell therapy that is derived from skin cells which are grown and then induced to differentiate into other types of cells, such as cardiac cells. iCRT-14 has been shown to be capable of reversing the progression of some types of breast cancer by activating transcription-polymerase chain reaction (PCR) and increasing epidermal growth factor levels. The activation of cell signaling pathways, such as c-jun phosphorylation, also plays a role in iCRT-14's effect on cancer cells.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 375.44 g/mol
• Formule: C₂₁H₁₇N₃O₂S
• Degré de pureté: Min. 95%